Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 3
2021 7
2022 10
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Explainable 3D CNN based on baseline breast DCE-MRI to give an early prediction of pathological complete response to neoadjuvant chemotherapy.
Comes MC, Fanizzi A, Bove S, Didonna V, Diotiaiuti S, Fadda F, La Forgia D, Giotta F, Latorre A, Nardone A, Palmiotti G, Ressa CM, Rinaldi L, Rizzo A, Talienti T, Tamborra P, Zito A, Lorusso V, Massafra R. Comes MC, et al. Comput Biol Med. 2024 Apr;172:108132. doi: 10.1016/j.compbiomed.2024.108132. Epub 2024 Mar 14. Comput Biol Med. 2024. PMID: 38508058 Free article.
Prognostic power assessment of clinical parameters to predict neoadjuvant response therapy in HER2-positive breast cancer patients: A machine learning approach.
Fanizzi A, Latorre A, Bavaro DA, Bove S, Comes MC, Di Benedetto EF, Fadda F, La Forgia D, Giotta F, Palmiotti G, Petruzzellis N, Rinaldi L, Rizzo A, Lorusso V, Massafra R. Fanizzi A, et al. Among authors: comes mc. Cancer Med. 2023 Nov;12(22):20663-20669. doi: 10.1002/cam4.6512. Epub 2023 Oct 31. Cancer Med. 2023. PMID: 37905688 Free PMC article.
Machine learning survival models trained on clinical data to identify high risk patients with hormone responsive HER2 negative breast cancer.
Fanizzi A, Pomarico D, Rizzo A, Bove S, Comes MC, Didonna V, Giotta F, La Forgia D, Latorre A, Pastena MI, Petruzzellis N, Rinaldi L, Tamborra P, Zito A, Lorusso V, Massafra R. Fanizzi A, et al. Among authors: comes mc. Sci Rep. 2023 May 26;13(1):8575. doi: 10.1038/s41598-023-35344-9. Sci Rep. 2023. PMID: 37237020 Free PMC article.
Assessing the cost-effectiveness of waiting list reduction strategies for a breast radiology department: a real-life case study.
Fanizzi A, Graps E, Bavaro DA, Farella M, Bove S, Campobasso F, Comes MC, Cristofaro C, Forgia D, Milella M, Iacovelli S, Villani R, Signorile R, De Bartolo A, Lorusso V, Massafra R. Fanizzi A, et al. Among authors: comes mc. BMC Health Serv Res. 2023 May 23;23(1):526. doi: 10.1186/s12913-023-09447-y. BMC Health Serv Res. 2023. PMID: 37221516 Free PMC article.
Analyzing breast cancer invasive disease event classification through explainable artificial intelligence.
Massafra R, Fanizzi A, Amoroso N, Bove S, Comes MC, Pomarico D, Didonna V, Diotaiuti S, Galati L, Giotta F, La Forgia D, Latorre A, Lombardi A, Nardone A, Pastena MI, Ressa CM, Rinaldi L, Tamborra P, Zito A, Paradiso AV, Bellotti R, Lorusso V. Massafra R, et al. Among authors: comes mc. Front Med (Lausanne). 2023 Feb 2;10:1116354. doi: 10.3389/fmed.2023.1116354. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36817766 Free PMC article.
Lean Perspectives in an Organizational Change in a Scientific Direction of an Italian Research Institute: Experience of the Cancer Institute of Bari.
La Forgia D, Paparella G, Signorile R, Arezzo F, Comes MC, Cormio G, Daniele A, Fanizzi A, Fioretti AM, Gatta G, Lafranceschina M, Rizzo A, Zaccaria GM, Rosa A, Massafra R. La Forgia D, et al. Among authors: comes mc. Int J Environ Res Public Health. 2022 Dec 23;20(1):239. doi: 10.3390/ijerph20010239. Int J Environ Res Public Health. 2022. PMID: 36612562 Free PMC article.
31 results